Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 2146 AL 2160

Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer's Disease

Pokrzyk J, Kulczyńska-Przybik A, Guzik-Makaruk E, Winkel I, Mroczko B.

Int J Mol Sci. 2025 Feb 24;26(5):1935. doi: 10.3390/ijms26051935.

Successes and failures: the latest advances in the clinical development of amyloid-β-targeting monoclonal antibodies for treating Alzheimer's disease

Panza F, Dibello V, Sardone R, Zupo R, Castellana F, Leccisotti I, Moretti MC, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Resta E, Lozupone M.

Expert Opin Biol Ther. 2025 Mar;25(3):275-283. doi: 10.1080/14712598.2025.2463963. Epub 2025 Feb 7.

Recent molecular insights and biosensor-based diagnostic technologies for hyperphosphorylated Tau in Alzheimer's disease

Shabana S, Hamouda HI, Shang A, Shao S, Zhao J, Yuan H, Liu B.

Alzheimers Res Ther. 2025 Dec 17;18(1):5. doi: 10.1186/s13195-025-01932-2.

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery

Videla L, Benejam B, Barroeta I, Fernandez S, Altuna M, Arranz J, Rodríguez-Baz Í, Arriola-Infante JE, Maure-Blesa L, Del Hoyo Soriano L, Illán-Gala I, Estellés T, Sanjuan A, Vaqué-Alcázar L, Aranha MR, Morcillo-Nieto AO, Zsadanyi SE, Franquesa-Mullerat M, Valldeneu S, Sánchez-Saudinós MB, Padilla C, Carreras M, Lorente O, Valle-Tamayo N, Sánchez-Aced É, Dols-Icardo O, Sirisi S, Muñoz L, Torres S, Bounasr El Bennadi SE, Sánchez O, Garzón D, Ribas L, Elbachiri S, Mota C, Tondo M, Camacho V, Giménez S, Delaby C, Belbin O, Iulita MF, Montal V, Pegueroles J, Vilaplana E, Clarimón J, González-Ortiz S, Molina-Porcel L, Aldecoa I, Alcolea D, Bejanin A, Videla S, Blesa R, Lleó A, Carmona-Iragui M, Fortea J.

Alzheimers Dement. 2025 Jun;21(6):e70259. doi: 10.1002/alz.70259.

The moderating effect of cognitive reserve on the association between neuroimaging biomarkers and cognition: A systematic review

Guo L, Zhou Y, Lu H, Fung HH.

Neurobiol Aging. 2025 Dec;156:10-29. doi: 10.1016/j.neurobiolaging.2025.07.016. Epub 2025 Jul 30.

Utilizing machine learning algorithms to identify biomarkers associated with Alzheimer's disease and ferroptosis-related genes

Wang D, Lin C, Liu G, Wang X, Han S, Han Z.

Technol Health Care. 2025 Jul;33(4):2041-2063. doi: 10.1177/09287329251322278. Epub 2025 Mar 3.

Integration of Neuroimaging and Molecular Biomarkers in the Diagnosis of Alzheimer's Disease and Frontotemporal Dementia: The Promise of fMRI

Poszwa J, Słowikowski B, Owecki W, Szymanowicz O, Jagodzinski PP, Kozubski W, Dorszewska J.

Curr Alzheimer Res. 2025;22(7):477-487. doi: 10.2174/0115672050390340250716061313.

Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis

Antonioni A, Raho EM, Di Lorenzo F, Manzoli L, Flacco ME, Koch G.

J Neurol. 2025 Mar 6;272(3):252. doi: 10.1007/s00415-025-12996-3.

A systematic review: Brain age gap as a promising early diagnostic biomarker for Alzheimer's disease

Liu S, Xu L, Xu G, Wang Y, Zhang G, He L.

J Neurol Sci. 2025 Aug 15;475:123563. doi: 10.1016/j.jns.2025.123563. Epub 2025 Jun 3.

[Non-invasive biomarkers for early diagnosis of Alzheimer's disease in bodily fluids]

Kovalenko EA, Makhnovich EV, Pervunina AV, Gileva EA, Bogolepova AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(1):8-16. doi: 10.17116/jnevro20251250118.

Electrochemical biosensors for early detection of Alzheimer's disease

Matlyuba Jakhonkulovna S, Bahodirova Kamolovna G, Zokirov M, Umida Tajimuratovna B, Yumashev A, Shichiyakh R, Safarova NI, Nargiza Nusratovna A, Esanmuradova N, Muyassar Karimbaevna T, Lazizakhon A, Ishankulov A.

Clin Chim Acta. 2025 May 15;572:120278. doi: 10.1016/j.cca.2025.120278. Epub 2025 Apr 2.

Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's disease

Devanarayan V, Horie K, Wildsmith K, Doherty T, Andreozzi E, Charil A, Sachdev P, Kramer LD, Dhadda S, Irizarry MC.

Alzheimers Dement. 2025 Nov;21(11):e70881. doi: 10.1002/alz.70881.

Comparison of Plasma p-tau217 and [(18)F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia

Quispialaya KM, Therriault J, Aliaga A, Benedet AL, Ashton NJ, Karikari T, Cassa Macedo A, Rahmouni N, Tissot C, Fernandez Arias J, Wang YT, Trudel L, Hosseini SA, Matsudaira T, Chan T, Pascoal T, Gilfix B, Vitali P, Zimmer ER, Provost K, Soucy JP, Gauthier S, Zetterberg H, Jean-Claude BJ, Blennow K, Rosa-Neto P.

Neurology. 2025 Jan 28;104(2):e210211. doi: 10.1212/WNL.0000000000210211. Epub 2024 Dec 23.

The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review

Nasrallah IM, Kuo PH, Nordberg A, Bohnen NI, Ponisio MR.

AJR Am J Roentgenol. 2025 Nov;225(5):e2432325. doi: 10.2214/AJR.24.32325. Epub 2025 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias